| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10598405 | Bioorganic & Medicinal Chemistry Letters | 2005 | 5 Pages |
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Brenda L. Palucki, Min K. Park, Ravi P. Nargund, Zhixiong Ye, Iyassu K. Sebhat, Patrick G. Pollard, Rubana N. Kalyani, Rui Tang, Tanya MacNeil, David H. Weinberg, Aurawan Vongs, Charles I. Rosenblum, George A. Doss, Randall R. Miller, Ralph A. Stearns,
![First Page Preview: Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist](/preview/png/10598405.png)